Molecular Insights into the Potential Anticancer Activity of Pyrone Derivatives

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Pyrone derivatives are six-membered lactones with diverse biological activities.
• They target critical oncogenic signaling pathways including PI3K/Akt/mTOR, MAPK/ERK, Wnt/β-catenin, and Hedgehog.

Purpose of the Study:

• To investigate the multifaceted anticancer activities of pyrone derivatives.
• To evaluate their potential in overcoming cancer resistance mechanisms and improving therapeutic outcomes.

Main Methods:

• In vitro studies assessing cancer cell proliferation, apoptosis, cell cycle arrest, and chemosensitivity.
• Preclinical evaluation in xenograft models, including those with KRAS mutations and therapy resistance.
• Assessment of anti-angiogenic effects via VEGF signaling inhibition.

Main Results:

• Pyrone derivatives suppress proliferation and induce apoptosis in various cancer cells.
• They downregulate cancer stemness markers, reverse multidrug resistance, and enhance chemosensitivity.
• Efficacy demonstrated in preclinical models, with synergistic effects when combined with conventional therapies; anti-angiogenic properties observed.

Conclusions:

• Pyrone derivatives exhibit significant therapeutic potential against diverse cancers, including resistant types.
• Challenges in solubility, bioavailability, and toxicity require innovative strategies like nanoparticle delivery and structural modification.
• Further clinical validation and pharmacokinetic optimization are crucial for their translation into precision oncology.